Skip to Main Content

Author Details

Agnes C Paquet
Universite Cote d'Azur, CNRS UMR5
2004
58
28
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36042886Coupling live-cell imaging and <i>in situ</i> isolation of the same single cell to profile the transient states of predicted drug-tolerant cells.STAR Protoc2022
32978064Evidence of early increased sialylation of airway mucins and defective mucociliary clearance in CFTR-deficient piglets.J Cyst Fibros2021
35664983Preclinical assessment of dual CYP26[A1/B1] inhibitor, DX308, as an improved treatment for keratinization disorders.Skin Health Dis2021
33686243Correction: The nuclear hypoxia-regulated NLUCAT1 long non-coding RNA contributes to an aggressive phenotype in lung adenocarcinoma through regulation of oxidative stress.Oncogene2021
32559766Immunoglobulin light-chain toxicity in a mouse model of monoclonal immunoglobulin light-chain deposition disease.Blood2020
33099406Profiling the Non-genetic Origins of Cancer Drug Resistance with a Single-Cell Functional Genomics Approach Using Predictive Cell Dynamics.Cell Syst2020
32726565A Single-Cell Atlas of the Human Healthy Airways.Am J Respir Crit Care Med2020
32526884Inhibition of Patched Drug Efflux Increases Vemurafenib Effectiveness against Resistant Braf<sup>V600E</sup> Melanoma.Cancers (Basel)2020
30964696The Long Noncoding RNA DNM3OS Is a Reservoir of FibromiRs with Major Functions in Lung Fibroblast Response to TGF-β and Pulmonary Fibrosis.Am J Respir Crit Care Med2019
30089916The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia.Leukemia2019
31558434Novel dynamics of human mucociliary differentiation revealed by single-cell RNA sequencing of nasal epithelial cultures.Development2019
30703773CD4+ T Cells Affect the Thyroid Hormone Transport at the Choroid Plexus in Mice Raised in Enriched Environment.Neuroimmunomodulation2019
30827861GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors.Cell Metab2019
28575140Optimizing drug development in oncology by clinical trial simulation: Why and how?Brief Bioinform2018
30190271The "one airway, one disease" concept in light of Th2 inflammation.Eur Respir J2018
29858030Effect of mutant variants of the KRAS gene on PD-L1 expression and on the immune microenvironment and association with clinical outcome in lung adenocarcinoma patients.Lung Cancer2018
29950983CD4<sup>+</sup> T Cells Have a Permissive Effect on Enriched Environment-Induced Hippocampus Synaptic Plasticity.Front Synaptic Neurosci2018
30405130CDC20B is required for deuterosome-mediated centriole production in multiciliated cells.Nat Commun2018
30319351New Insights Into the Role of Ca<sub>v</sub>2 Protein Family in Calcium Flux Deregulation in <i>Fmr1</i>-KO Neurons.Front Mol Neurosci2018
29362864Tacrolimus-induced nephrotoxicity in mice is associated with microRNA deregulation.Arch Toxicol2018
29668986HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation protein.Nucleic Acids Res2018
29175168CD8<sup>+</sup> T cells are essential for the effects of enriched environment on hippocampus-dependent behavior, hippocampal neurogenesis and synaptic plasticity.Brain Behav Immun2018
27940562A cost effective 5ο selective single cell transcriptome profiling approach with improved UMI design.Nucleic Acids Res2017
28192603Characterizing isomiR variants within the microRNA-34/449 family.FEBS Lett2017
27686867Copy-number analysis identified new prognostic marker in acute myeloid leukemia.Leukemia2017
26795242SENS-IS, a 3D reconstituted epidermis based model for quantifying chemical sensitization potency: Reproducibility and predictivity results from an inter-laboratory study.Toxicol In Vitro2016
26645564SIGMAR1 Regulates Membrane Electrical Activity in Response to Extracellular Matrix Stimulation to Drive Cancer Cell Invasiveness.Cancer Res2016
27347386RiboProfiling: a Bioconductor package for standard Ribo-seq pipeline processing.F1000Res2016
25681308Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases.Neuro Oncol2015
26035830Inflammatory and repair pathways induced in human bronchoalveolar lavage cells with ozone inhalation.PLoS One2015
25886996Quantitative measurement of HER2 expression in breast cancers: comparison with 'real-world' routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival.Breast Cancer Res2015
25684627Trends in darunavir resistance-associated mutations and phenotypic resistance in commercially tested United States clinical samples between 2006 and 2012.AIDS Res Hum Retroviruses2015
23922373HIV type 1 polymerase gene polymorphisms are associated with phenotypic differences in replication capacity and disease progression.J Infect Dis2014
24518099A decade of HIV-1 drug resistance in the United States: trends and characteristics in a large protease/reverse transcriptase and co-receptor tropism database from 2003 to 2012.Antivir Ther2014
24668646Quantitative measurements of tumoral p95HER2 protein expression in metastatic breast cancer patients treated with trastuzumab: independent validation of the p95HER2 clinical cutoff.Clin Cancer Res2014
24646213Predicting HIV-1 broadly neutralizing antibody epitope networks using neutralization titers and a novel computational method.BMC Bioinformatics2014
23612580Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1.Cardiovasc Res2013
23859270A case-based reasoning system for genotypic prediction of HIV-1 co-receptor tropism.J Bioinform Comput Biol2013
23892128Minimal sequence variability of the region of HIV-1 integrase targeted by the Abbott RealTime HIV-1 viral load assay in clinical specimens with reduced susceptibility to raltegravir.J Virol Methods2013
23959396HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer.Breast Cancer Res Treat2013
22098079Short communication: Phenotypic protease inhibitor resistance and cross-resistance in the clinic from 2006 to 2008 and mutational prevalences in HIV from patients with discordant tipranavir and darunavir susceptibility phenotypes.AIDS Res Hum Retroviruses2012
22848366Correlation of HER2, p95HER2 and HER3 expression and treatment outcome of lapatinib plus capecitabine in her2-positive metastatic breast cancer.PLoS One2012
22234627Correlation between quantitative HER-2 protein expression and risk for brain metastases in HER-2+ advanced breast cancer patients receiving trastuzumab-containing therapy.Oncologist2012
21285132Very high quantitative tumor HER2 content and outcome in early breast cancer.Ann Oncol2011
21297946Differences in reversion of resistance mutations to wild-type under structured treatment interruption and related increase in replication capacity.PLoS One2011
21289364Identification of a subpopulation of metastatic breast cancer patients with very high HER2 expression levels and possible resistance to trastuzumab.Ann Oncol2011
19996317Transforming growth factor beta1 inhibits cystic fibrosis transmembrane conductance regulator-dependent cAMP-stimulated alveolar epithelial fluid transport via a phosphatidylinositol 3-kinase-dependent mechanism.J Biol Chem2010
21151530Analytical Validation of a Highly Quantitative, Sensitive, Accurate, and Reproducible Assay (HERmark) for the Measurement of HER2 Total Protein and HER2 Homodimers in FFPE Breast Cancer Tumor Specimens.Patholog Res Int2010
20661914Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization-positive patients with metastatic breast cancer treated with trastuzumab.Cancer2010
20660336Comparison of central HER2 testing with quantitative total HER2 expression and HER2 homodimer measurements using a novel proximity-based assay.Am J Clin Pathol2010
  • 1 - 50 of 58

Recommended Authors

J. David Gladstone Institutes
Career Start Year 2014
Number of shared co-authors 2
Center for Clinical and Translational Science, Rockefeller University
Career Start Year 2013
Number of shared co-authors 0
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 0
Immuneering Corporation
Career Start Year 2012
Number of shared co-authors 0
Oregon National Primate Research Center
Career Start Year 2010
Number of shared co-authors 0
Fred Hutchinson Cancer Center
Career Start Year 2009
Number of shared co-authors 2
Institute for Systems Biology
Career Start Year 2007
Number of shared co-authors 0
Stanford University
Career Start Year 2006
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 2004
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2004
Number of shared co-authors 0
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 1
University of California
Career Start Year 2003
Number of shared co-authors 0
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 0
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 2
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 0
Medical University of Vienna
Career Start Year 2001
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 0
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 0
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 0
Oregon Health & Science University, University of California Berkeley
Career Start Year 1997
Number of shared co-authors 1
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Uniformed Services University of the Health Sciences
Career Start Year 1997
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 1
Cedars-Sinai Medical Center
Career Start Year 1992
Number of shared co-authors 0
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 0
J. Craig Venter Institute
Career Start Year 1983
Number of shared co-authors 0

Collaborators

The University of Sydney
Co-authored papers 3
University of California San Francisco
Co-authored papers 2
Hadassah Hebrew University Medical Center
Co-authored papers 2
Department of Medicine Johns Hopkins Medicine. Baltimore MD 21205USA.
Co-authored papers 2
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Co-authored papers 2
Stanford University
Co-authored papers 2
University of California, USA Center for Reproductive Sciences san francisco
Co-authored papers 2
Indian Institute of Science Education and Research Pune
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Raigmore Hospital
Co-authored papers 1
Cooper University Hospital
Co-authored papers 1
Indiana University School of Medicine
Co-authored papers 1
Cardiovascular Research Institute, University of California san francisco
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
University of Montpellier, CNRS
Co-authored papers 1
Center for Personal Dynamic Regulomes, Stanford University
Co-authored papers 1
Inc., Collegeville
Co-authored papers 1
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Genentech Inc.
Co-authored papers 1
Institut de Recherche Saint-Louis, Universite de Paris
Co-authored papers 1
Co-authored papers 1
University of Minnesota-Twin Cities
Co-authored papers 1
David Geffen School of Medicine, University of California los angeles
Co-authored papers 1
University of Paris
Co-authored papers 1